$5 Million in Funding: In April 2025, Serina secured $5 million from strategic shareholders to support the continued development of SER-252 (POZ-apomorphine), Serina's lead clinical candidate for ...

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.

DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

Etanercept is a recombinant human tumor necrosis factor (TNF) receptor fusion protein. It acts as a biologic ...

CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled ‘A Multicenter, ...

Prescription drug policy is back in the spotlight, with policymakers debating everything from price controls and research ...

While the injections from Lilly and Novo have revolutionized the way obesity is treated, investors say pills are key to ...

Emma Charles shares her vision for healthcare, how AI is reshaping pharma and why access to innovation must be faster and ...